comparemela.com

Latest Breaking News On - Skin blood - Page 1 : comparemela.com

BioVie Announces Efficacy Data from Phase 3 Trial of

BioVie Inc Announces Efficacy Data from Phase 3 Trial of NE3107 in Patients with Mild to Moderate Alzheimer?s Disease

BioVie Inc., announced positive analysis of unblinded, topline efficacy data from its Phase 3 clinical trial of NE3107 in the treatment of mild to moderate Alzheimer?s Disease . Data from evaluable.

BioVie Announces Efficacy Data from Phase 3 Trial of NE3107 in Patients with Mild to Moderate Alzheimer s Disease

29.11.2023 - Positive Trending Data from 57 Per-Protocol Patients Suggest NE3107 is Biologically Active and May Have Impact on Cognitive, Functional, and Biomarker Endpoints Sponsor Identified Issues Relating to Significant GCP Violations and Protocol .

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.